Regulation of tumor pH and the role of carbonic anhydrase 9

Cancer and Metastasis Reviews

Volumn 26, Issue 2, 2007, Pages 299-310

  Swietach, Pawel ^a   Vaughan Jones, Richard D ^a   Harris, Adrian L ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Fluorescence; Hypoxia; Imaging; Intracellular and extracellular pH; Nuclear magnetic resonance

Indexed keywords

BICARBONATE; CARBON DIOXIDE; CARBONATE DEHYDRATASE IX; HYDROGEN; HYPOXIA INDUCIBLE FACTOR 1; LACTIC ACID;

APOPTOSIS; CANCER; CATALYSIS; CELL MEMBRANE; CELL PH; CELL SURFACE; CYTOSOL; GLYCOLYSIS; HUMAN; LACTIC ACIDOSIS; METASTASIS; PENTOSE PHOSPHATE CYCLE; PH; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STROMA; TUMOR CELL; UPREGULATION;

ANTIGENS, NEOPLASM; BICARBONATES; CARBON DIOXIDE; CARBONIC ANHYDRASES; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MODELS, BIOLOGICAL; NEOPLASMS; REFERENCE VALUES;

EID: 34447547148     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-007-9064-0     Document Type: Review

References (103)

1. Roos, A., & Boron, W. F. (1981). Intracellular pH. Physiological Reviews, 61, 296-434.
2. De Brabander, M., Geuens, G., Nuydens, R., Willebrords, R., & De Mey, J. (1982). Microtubule stability and assembly in living cells: The influence of metabolic inhibitors, taxol and pH. Cold Spring Harbor Symposia on Quantitative Biology, 1, 227-240, 46 Pt.
3. Isfort, R. J., Cody, D. B., Asquith, T. N., Ridder, G. M., Stuard, S. B., & LeBoeuf, R. A. (1993). Induction of protein phosphorylation, protein synthesis, immediate-early-gene expression and cellular proliferation by intracellular pH modulation. Implications for the role of hydrogen ions in signal transduction. European Journal of Biochemistry, 213, 349-357.
4. Morita, T., Nagaki, T., Fukuda, I., & Okumura, K. (1992). Clastogenicity of low pH to various cultured mammalian cells. Mutation Research, 268, 297-305.
5. McConkey, D. J., & Orrenius, S. (1996). Signal transduction pathways in apoptosis. Stem Cells, 14, 619-631.
6. Warburg, O. (1930). The metabolism of tumours. London: Arnold Constable.
7. Kallinowski, F., Schlenger, K. H., Runkel, S., Kloes, M., Stohrer, M., Okunieff, P., et al. (1989). Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Research, 49, 3759-3764.
8. Wike-Hooley, J. L., Haveman, J., & Reinhold, H. S. (1984). The relevance of tumour pH to the treatment of malignant disease. Radiotherapy and Oncology, 2, 343-366.
9. Griffiths, J. R., Stevens, A. N., Iles, R. A., Gordon, R. E., & Shaw, D. (1981). 31P-NMR investigation of solid tumours in the living rat. Bioscience Reports, 11, 319-325.
10. Gillies, R. J., Liu, Z., & Bhujwalla, Z. (1994). 31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate. American Journal of Physiology, 267, C195-C203.
11. Gil, S., Zaderenzo, P., Cruz, F., Cerdan, S., & Ballesteros, P. (1994). Imidazol-1-ylalkanoic acids as extrinsic 1H NMR probes for the determination of intracellular pH, extracellular pH and cell volume. Bioorganic & Medicinal Chemistry, 2, 305-314.
12. Gatenby, R. A., Gawlinski, E. T., Gmitro, A. F., Kaylor, B, Gillies, R. J. (2006). Acid-mediated tumor invasion: a multidisciplinary study. Cancer Research, 66, 5216-5223.
13. Swietach, P., Wigfield, S., Harris, A., & Vaughan-Jones, R. (2007). Extracellular-facing carbonic anhydrase IX helps to dissipate pH non-uniformity and coordinates pH regulation across large clusters of cells. In Experimental Biology Annual Meeting, Washington D.C.
14. Vaupel, P., Kallinowski, F., & Okunieff, P. (1990). Blood flow, oxygen consumption and tissue oxygenation of human tumors. Advances in Experimental Medicine and Biology, 277, 895-905.
15. Gillies, R. J., Raghunand, N., Karczmar, G. S., & Bhujwalla, Z. M. (2002). MRI of the tumor microenvironment. Journal of Magnetic Resonance Imaging, 16, 430-450.
16. Koukourakis, M. I., Pitiakoudis, M., Giatromanolaki, A., Tsarouha, A., Polychronidis, A., Sivridis, E., et al. (2006). Oxygen and glucose consumption in gastrointestinal adenocarcinomas: Correlation with markers of hypoxia, acidity and anaerobic glycolysis. Cancer Science, 97, 1056-1060.
17. Gatenby, R. A., & Gillies, R. J. (2004). Why do cancers have high aerobic glycolysis? Nature Reviews Cancer, 4, 891-899.
18. Martinez-Zaguilan, R., Seftor, E. A., Seftor, R. E., Chu, Y. W., Gillies, R. J., & Hendrix, M. J. (1996). Acidic pH enhances the invasive behavior of human melanoma cells. Clinical & Experimental Metastasis, 14, 176-186.
19. Schlappack, O. K., Zimmermann, A., & Hill, R. P. (1991). Glucose starvation and acidosis: Effect on experimental metastatic potential, DNA content and MTX resistance of murine tumour cells. British Journal of Cancer, 64, 663-670.
20. Kato, Y., Nakayama, Y., Umeda, M., & Miyazaki, K. (1992). Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. Journal of Biological Chemistry, 267, 11424-11430.
21. Gatenby, R. A., & Gawlinski, E. T. (1996). A reaction-diffusion model of cancer invasion. Cancer Research, 56, 5745-5753.
22. Park, H. J., Lyons, J. C., Ohtsubo, T., & Song, C. W. (1999). Acidic environment causes apoptosis by increasing caspase activity. British Journal of Cancer, 80, 1892-1897.
23. Moolenaar, W. H. (1986). Effects of growth factors on intracellular pH regulation. Annual Review of Physiology, 48, 363-376.
24. Williams, A. C., Collard, T. J., & Paraskeva, C. (1999). An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: implications for clonal selection during colorectal carcinogenesis. Oncogene, 18, 3199-3204.
25. McLean, L. A., Roscoe, J., Jorgensen, N. K., Gorin, F. A., & Cala, P. M. (2000). Malignant gliomas display altered pH regulation by NHE1 compared with nontransformed astrocytes. American Journal of Physiology. Cell Physiology, 278, C676-C688.
26. Lee, A. H., & Tannock, I. F. (1998). Heterogeneity of intracellular pH and of mechanisms that regulate intracellular pH in populations of cultured cells. Cancer Research, 58, 1901-1908.
27. Martinez-Zaguilan, R., Lynch, R. M., Martinez, G. M., & Gillies, R. J. (1993). Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. American Journal of Physiology, 265, C1015-C1029.
28. Gillies, R. J., Martinez-Zaguilan, R., Martinez, G. M., Serrano, R., & Perona, R. (1990). Tumorigenic 3T3 cells maintain an alkaline intracellular pH under physiological conditions. Proceedings of the National Academy of Sciences of the United States of America, 87, 7414-7418.
29. Reshkin, S. J., Bellizzi, A., Caldeira, S., Albarani, V., Malanchi, I., Poignee, M., et al. (2000). Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB Journal, 14, 2185-2197.
30. Weber, W. A. (2006). Positron emission tomography as an imaging biomarker. Journal of Clinical Oncology, 24, 3282-3292.
31. Gambhir, S. S. (2002). Molecular imaging of cancer with positron emission tomography. Nature Reviews. Cancer, 2, 683-693.
32. Dewhirst, M. W., Secomb, T. W., Ong, E. T., Hsu, R., & Gross, J. F. (1994). Determination of local oxygen consumption rates in tumors. Cancer Research, 54, 3333-3336.
33. Krogh, A. (1919). The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue. Journal of Physiology, 52, 409-415.
34. Li, X., Vigneron, D. B., Cha, S., Graves, E. E., Crawford, F., Chang, S. M., et al. (2005). Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo. AJNR. American Journal of Neuroradiology, 26, 760-769.
35. Hockel, M., & Vaupel, P. (2001). Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. Journal of the National Cancer Institute, 93, 266-276.
36. Semenza, G. L., & Wang, G. L. (1992). A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Molecular and Cellular Biology, 12, 5447-5454.
37. Gleadle, J. M., & Ratcliffe, P. J. (1998). Hypoxia and the regulation of gene expression. Molecular Medicine Today, 4, 122-129.
38. Semenza, G. L. (2003). Targeting HIF-1 for cancer therapy. Nature Reviews Cancer, 3, 721-732.
39. Minchenko, A., Leshchinsky, I., Opentanova, I., Sang, N., Srinivas, V., Armstead, V., et al. (2002). Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. Journal of Biological Chemistry, 277, 6183-6187.
40. Semenza, G. L., Roth, P. H., Fang, H. M., & Wang, G. L. (1994). Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. Journal of Biological Chemistry, 269, 23757-23763.
41. Semenza, G. L., Jiang, B. H., Leung, S. W., Passantino, R., Concordet, J. P., Maire, P., et al. (1996). Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. Journal of Biological Chemistry, 271, 32529-32537.
42. Kim, J. W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006). HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metabolism, 3, 177-185.
43. Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006). HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metabolism, 3, 187-197.
44. Baudelet, C., Ansiaux, R., Jordan, B. F., Havaux, X., Macq, B., & Gallez, B. (2004). Physiological noise in murine solid tumours using T2*-weighted gradient-echo imaging: A marker of tumour acute hypoxia? Physics in Medicine & Biology, 49, 3389-3411.
45. Plas, D. R., & Thompson, C. B. (2005). Akt-dependent transformation: There is more to growth than just surviving. Oncogene, 24, 7435-7442.
46. Kallinowski, F., Tyler, G., Mueller-Klieser, W., & Vaupel, P. (1989). Growth-related changes of oxygen consumption rates of tumor cells grown in vitro and in vivo. Journal of Cellular Physiology, 138, 183-191.
47. Hochachka, P. W., &. Mommsen, T. P. (1983). Protons and anaerobiosis. Science, 219, 1391-1397.
48. Vaupel, P., Kallinowski, F., & Okunieff, P. (1989). Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Research, 49, 6449-6465.
49. Dickson, J. A., & Calderwood, S. K. (1979). Effects of hyperglycemia and hyperthermia on the pH, glycolysis, and respiration of the Yoshida sarcoma in vivo. Journal of the National Cancer Institute, 63, 1371-1381.
50. Kalmus, J., Okunieff, P., & Vaupel, P. (1989). Effect of intraperitoneal versus intravenous glucose administration on laser Doppler flow in murine FSaII tumors and normal skin. Cancer Research, 49, 6313-6317.
51. Halestrap, A. P., & Meredith, D. (2004). The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Archiv: European Journal of Physiology, 447, 619-628.
52. Halestrap, A. P., & Price, N. T. (1999). The proton-linked monocarboxylate transporter (MCT) family: Structure, function and regulation. Biochemical Journal, 343(Pt 2), 281-299.
53. Ord, J. J., Streeter, E. H., Roberts, I. S., Cranston, D., & Harris, A. L. (2005). Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer. British Journal of Cancer, 93, 346-354.
54. Ullah, M. S., Davies, A. J., & Halestrap, A. P. (2006). The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. Journal of Biological Chemistry, 281, 9030-9037.
55. Newell, K., Franchi, A., Pouyssegur, J., & Tannock, I. (1993). Studies with glycolysis-deficient cells suggest that production of lactic acid is not the only cause of tumor acidity. Proceedings of the National Academy of Sciences of the United States of America, 90, 1127-1131.
56. Yamagata, M., Hasuda, K., Stamato, T., & Tannock, I. F. (1998). The contribution of lactic acid to acidification of tumours: Studies of variant cells lacking lactate dehydrogenase. British Journal of Cancer, 77, 1726-1731.
57. Gullino, P. M., Grantham, F. H., Smith, S. H., & Haggerty, A. C. (1965). Modifications of the acid-base status of the internal milieu of tumors. Journal of the National Cancer Institute, 34, 857-869.
58. Helmlinger, G., Sckell, A., Dellian, M., Forbes, N. S., & Jain, R. K. (2002). Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clinical Cancer Research, 8, 1284-1291.
59. Meyerson, L. R., & Nesta, D. (1991). [3H]acetazolamide binding to carbonic anhydrase in normal and transformed cells. Biochemical Pharmacology, 41, 995-1000.
60. Scozzafava, A., Mastrolorenzo, A., & Supuran, C. (2006). Carbonic anhydrase inhibitors and activators and their use in therapy. Expert Opinion on Therapeutic Patents, 16, 1627-1666.
61. Esbaugh, A. J., & Tufts, B. L. (2006). The structure and function of carbonic anhydrase isozymes in the respiratory system of vertebrates. Respiration Physiology. Neurobiology, 154, 185-198.
62. Sterling, D., Reithmeier, R. A., & Casey, J. R. (2001). A transport metabolon. Functional interaction of carbonic anhydrase II and chloride/bicarbonate exchangers. Journal of Biological Chemistry, 276, 47886-47894.
63. Wingo, T., Tu, C., Laipis, P. J., & Silverman, D. N. (2001). The catalytic properties of human carbonic anhydrase IX. Biochemical and Biophysical Research Communications, 288, 666-669.
64. Pastorekova, S., Zavadova, Z., Kostal, M., Babusikova, O., & Zavada, J. (1992). A novel quasi-viral agent, MaTu, is a two-component system. Virology, 187, 620-626.
65. Opavsky, R., Pastorekova, S., Zelnik, V., Gibadulinova, A., Stanbridge, E. J., Zavada, J., et al. (1996). Human MN/CA9 gene, a novel member of the carbonic anhydrase family: Structure and exon to protein domain relationships. Genomics, 33, 480-487.
66. Pastorek, J., Pastorekova, S., Callebaut, I., Mornon, J. P., Zelnik, V., Opavsky, R., et al. (1994). Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix- loop-helix DNA binding segment. Oncogene, 9, 2877-2888.
67. Dorai, T., Sawczuk, I. S., Pastorek, J., Wiernik, P. H., & Dutcher, J. P. (2005). The role of carbonic anhydrase IX overexpression in kidney cancer. European Journal of Cancer, 41, 2935-2947.
68. Svastova, E., Zilka, N., Zat'ovicova, M., Gibadulinova, A., Ciampor, F., Pastorek, J., & Pastorekova, S. (2003). Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin. Experimental Cell Research, 290, 332-345.
69. Zatovicova, M., Sedlakova, O., Svastova, E., Ohradanova, A., Ciampor, F., Arribas, J., et al. (2005). Ectodomain shedding of the hypoxia-induced carbonic anhydrase IX is a metalloprotease-dependent process regulated by TACE/ADAM17. British Journal of Cancer, 93, 1267-1276.
70. Pastorekova, S., Parkkila, S., Parkkila, A. K., Opavsky, R., Zelnik, V., Saarnio, J., et al. (1997). Carbonic anhydrase IX, MN/CA IX: Analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. Gastroenterology, 112, 398-408.
71. Wykoff, C. C., Beasley, N. J., Watson, P. H., Turner, K. J., Pastorek, J., Sibtain, A., et al. (2000). Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Research, 60, 7075-7083.
72. Haapasalo, J. A., Nordfors, K. M., Hilvo, M., Rantala, I. J., Soini, Y., Parkkila, A. K., et al. (2006). Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis. Clinical Cancer Research, 12, 473-477.
73. Driessen, A., Landuyt, W., Pastorekova, S., Moons, J., Goethals, L., Haustermans, K., et al. (2006). Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas. Annals of Surgery, 243, 334-340.
74. Chia, S. K., Wykoff, C. C., Watson, P. H., Han, C., Leek, R. D., Pastorek, J., et al. (2001). Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase ix, in invasive breast carcinoma. Journal of Clinical Oncology, 19, 3660-3668.
75. Beasley, N. J., Wykoff, C. C., Watson, P. H., Leek, R., Turley, H., Gatter, K., et al. (2001). Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Research, 61, 5262-5267.
76. Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Simopoulos, K., Pastorek, J., Wykoff, C. C., et al. (2001). Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Clinical Cancer Research, 7, 3399-3403.
77. Ivanov, S., Liao, S. Y., Ivanova, A., Danilkovitch-Miagkova, A., Tarasova, N., Weirich, G., et al. (2001). Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. American Journal of Pathology, 158, 905-919.
78. Pastorekova, S., Pastorek, J. (2004). Cancer-related carbonic anhydrase isozymes and their inhibition. In C. Supuran, A. Scozzafava, & J. Conway (Eds.) Carbonic anhydrase: Its inhibitors and activators. Boca Raton, FL: CRC.
79. Generali, D., Fox, S. B., Berruti, A., Brizzi, M. P., Campo, L., Bonardi, S., et al. (2006). Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer. Endocrine-related Cancer, 13, 921-930.
80. Loncaster, J. A., Harris, A. L., Davidson, S. E., Logue, J. P., Hunter, R. D., Wycoff, C. C., et al. (2001). Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: Correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Research, 61, 6394-6399.
81. Airley, R. E., Loncaster, J., Raleigh, J. A., Harris, A. L., Davidson, S. E., Hunter, R. D., et al. (2003). GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: Relationship to pimonidazole binding. International Journal of Cancer, 104, 85-91.
82. Koukourakis, M. I., Giatromanolaki, A., Harris, A. L., & Sivridis, E. (2006). Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: A metabolic survival role for tumor-associated stroma. Cancer Research, 66, 632-637.
83. Robertson, N., Potter, C., & Harris, A. L. (2004). Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion. Cancer Research, 64, 6160-6165.
84. Bartosova, M., Parkkila, S., Pohlodek, K., Karttunen, T. J., Galbavy, S., Mucha, V., et al. (2002). Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2. Journal of Pathology, 197, 314-321.
85. Giatromanolaki, A., Koukourakis, M. I., Sivridis, E., Pastorek, J., Wykoff, C. C., Gatter, K. C., et al. (2001). Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Research, 61, 7992-7998.
86. Svastova, E., Hulikova, A., Rafajova, M., Zat'ovicova, M., Gibadulinova, A., Casini, A., et al. (2004). Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Letters, 577, 439-445.
87. Henry, R. P., & Swenson, E. R. (2000). The distribution and physiological significance of carbonic anhydrase in vertebrate gas exchange organs. Respiration Physiology, 121, 1-12.
88. Leem, C. H., Vaughan-Jones, R. D. (1998). Out-of-equilibrium pH transients in the guinea-pig ventricular myocyte. Journal of Physiology, 509(Pt 2), 471-485.
89. Swietach, P., Browning, J. A., Wilkins, R. J. (2002). Functional and molecular determination of carbonic anhydrase levels in bovine and cultured human chondrocytes. Comparative Biochemistry and Physiology. B. Biochemistry and Molecular Biology, 133, 427-435.
90. Stewart, A. K., Boyd, C. A., & Vaughan-Jones, R. D. (1999). A novel role for carbonic anhydrase: Cytoplasmic pH gradient dissipation in mouse small intestinal enterocytes. Journal of Physiology, 516(Pt 1), 209-217.
91. Spitzer, K. W., Skolnick, R. L., Peercy, B. E., Keener, J. P., Vaughan-Jones, R. D. (2002). Facilitation of intracellular H(+) ion mobility by CO(2)/HCO(3)(-) in rabbit ventricular myocytes is regulated by carbonic anhydrase. Journal of Physiology, 541, 159-167.
92. Irving, M., Maylie, J., Sizto, N. L., & Chandler, W. K. (1990). Intracellular diffusion in the presence of mobile buffers. Application to proton movement in muscle. Biophysical Journal, 57, 717-721.
93. Geers, C., & Gros, G. (2000). Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiological Reviews, 80, 681-715.
94. Heming, T. A., Stabenau, E. K., Vanoye, C. G., Moghadasi, H., & Bidani, A. (1994). Roles of intra- and extracellular carbonic anhydrase in alveolar-capillary CO2 equilibration. Journal of Applied Physiology, 77, 697-705.
95. Sterling, D., & Casey, J. R. (2002). Bicarbonate transport proteins. Biochemistry and Cell Biology, 80, 483-497.
96. Lu, J., Daly, C. M., Parker, M. D., Gill, H. S., Piermarini, P. M., Pelletier, M. F., et al. (2006). Effect of human carbonic anhydrase II on the activity of the human electrogenic Na/HCO3 cotransporter NBCe1-A in Xenopus oocytes. Journal of Biological Chemistry, 281, 19241-19250.
97. Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Gatter, K. C., Harris, A. L. (2005). Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma. Neoplasia, 7, 1-6.
98. Lu, H., Dalgard, C. L., Mohyeldin, A., McFate, T., Tait, A. S., & Verma, A. (2005). Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. Journal of Biological Chemistry, 280, 41928-41939.
99. Teicher, B. A., Liu, S. D., Liu, J. T., Holden, S. A., & Herman, T. S. (1993). A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. Anticancer Research, 13, 1549-1556.
100. Raghunand, N., & Gillies, R. J. (2001). pH and chemotherapy. Novartis Foundation Symposium, 240, 199-211; discussion: 265-198.
101. Ivanov, S. V., Kuzmin, I., Wei, M. H., Pack, S., Geil, L., Johnson, B. E., et al. (1998). Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. In Proceedings of the National Academy of Sciences of the United States of America, 95, 12596-12601.
102. Fantin, V. R., St-Pierre, J., & Leder, P. (2006). Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell, 9, 425-434.
103. Thiry, A., Dogne, J. M., Masereel, B., & Supuran, C. T. (2006). Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Trends in Pharmacological Sciences, 27, 566-573.